Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Martel

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Orphanet Journal of Rare Diseases|January 13, 2023
French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformationsNicolas Leboulanger, Annouk Bisdorff, Olivia Boccara, et al.
Cancers|May 16, 2023
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) BiobankArnaud Martel, Lauris Gastaud, Christelle Bonnetaud, et al.
Cell Death and Differentiation|January 19, 2021
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic diseaseCharlotte Pandiani, Thomas Strub, Nicolas Nottet, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
EMBO Molecular Medicine|November 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Orphanet Journal of Rare Diseases|January 13, 2023
French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformationsNicolas Leboulanger, Annouk Bisdorff, Olivia Boccara, et al.
Cancers|May 16, 2023
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) BiobankArnaud Martel, Lauris Gastaud, Christelle Bonnetaud, et al.
Cell Death and Differentiation|January 19, 2021
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic diseaseCharlotte Pandiani, Thomas Strub, Nicolas Nottet, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
EMBO Molecular Medicine|November 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 7